Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Pignata S, Scambia G, Schettino C, Arenare L, Pisano C, Lombardi D, De Giorgi U, Andreetta C, Cinieri S, De Angelis C, Priolo D, Casanova C, Rosati M, Greco F, Zafarana E, Schiavetto I, Mammoliti S, Cecere SC, Salutari V, Scalone S, Farolfi A, Di Napoli M, Lorusso D, Gargiulo P, Califano D, Russo D, Spina A, De Cecio R, Chiodini P, Perrone F; MITO investigators. Pignata S, et al. Among authors: di napoli m. Lancet Oncol. 2023 Mar;24(3):286-296. doi: 10.1016/S1470-2045(23)00016-5. Epub 2023 Feb 14. Lancet Oncol. 2023. PMID: 37052965 Clinical Trial.
Testicular and testicular adnexa tumors in the elderly.
Gigantino V, La Mantia E, Franco R, Cecere S, Rossetti S, Di Napoli M, Pisano C, Berretta M, Galzerano A, Botti G, Pignata S, Facchini G. Gigantino V, et al. Among authors: di napoli m. Anticancer Drugs. 2013 Mar;24(3):228-36. doi: 10.1097/CAD.0b013e32835a3598. Anticancer Drugs. 2013. PMID: 23059385 Review.
Multidisciplinary treatment of early stage endometrial cancer.
Cecere SC, Pisano C, Bamias A, Di Napoli M, Rossetti S, Facchini G, Tambaro R, Pignata S. Cecere SC, et al. Among authors: di napoli m. Anticancer Agents Med Chem. 2013 Jul 1;13(6):861-71. doi: 10.2174/18715206113139990111. Anticancer Agents Med Chem. 2013. PMID: 23194422
Intravesical chemo-immunotherapy in non muscle invasive bladder cancer.
Leopardo D, Cecere SC, Di Napoli M, Cavaliere C, Pisano C, Striano S, Marra L, Menna L, Claudio L, Perdonà S, Setola S, Berretta M, Franco R, Tambaro R, Pignata S, Facchini G. Leopardo D, et al. Among authors: di napoli m. Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2145-58. Eur Rev Med Pharmacol Sci. 2013. PMID: 23893180 Free article. Review.
Ovarian cancer standard of care: are there real alternatives?
Della Pepa C, Tonini G, Pisano C, Di Napoli M, Cecere SC, Tambaro R, Facchini G, Pignata S. Della Pepa C, et al. Among authors: di napoli m. Chin J Cancer. 2015 Jan;34(1):17-27. doi: 10.5732/cjc.014.10274. Chin J Cancer. 2015. PMID: 25556615 Free PMC article. Review.
Pazopanib plus weekly paclitaxel versus weekly paclitaxel alone for platinum-resistant or platinum-refractory advanced ovarian cancer (MITO 11): a randomised, open-label, phase 2 trial.
Pignata S, Lorusso D, Scambia G, Sambataro D, Tamberi S, Cinieri S, Mosconi AM, Orditura M, Brandes AA, Arcangeli V, Panici PB, Pisano C, Cecere SC, Di Napoli M, Raspagliesi F, Maltese G, Salutari V, Ricci C, Daniele G, Piccirillo MC, Di Maio M, Gallo C, Perrone F; MITO 11 investigators. Pignata S, et al. Among authors: di maio m, di napoli m. Lancet Oncol. 2015 May;16(5):561-8. doi: 10.1016/S1470-2045(15)70115-4. Epub 2015 Apr 14. Lancet Oncol. 2015. PMID: 25882986 Free article. Clinical Trial.
269 results